Suppr超能文献

中和抗体与高感染率渔业船舶暴发期间人类免受 SARS-CoV-2 感染相关。

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate.

机构信息

Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.

Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

出版信息

J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.02107-20.

Abstract

The development of vaccines against SARS-CoV-2 would be greatly facilitated by the identification of immunological correlates of protection in humans. However, to date, studies on protective immunity have been performed only in animal models and correlates of protection have not been established in humans. Here, we describe an outbreak of SARS-CoV-2 on a fishing vessel associated with a high attack rate. Predeparture serological and viral reverse transcription-PCR (RT-PCR) testing along with repeat testing after return to shore was available for 120 of the 122 persons on board over a median follow-up of 32.5 days (range, 18.8 to 50.5 days). A total of 104 individuals had an RT-PCR-positive viral test with a cycle threshold ( ) of <35 or seroconverted during the follow-up period, yielding an attack rate on board of 85.2% (104/122 individuals). Metagenomic sequencing of 39 viral genomes suggested that the outbreak originated largely from a single viral clade. Only three crew members tested seropositive prior to the boat's departure in initial serological screening and also had neutralizing and spike-reactive antibodies in follow-up assays. None of the crew members with neutralizing antibody titers showed evidence of bona fide viral infection or experienced any symptoms during the viral outbreak. Therefore, the presence of neutralizing antibodies from prior infection was significantly associated with protection against reinfection (Fisher's exact test,  = 0.002).

摘要

开发针对 SARS-CoV-2 的疫苗将极大地受益于在人类中确定免疫保护相关性。然而,迄今为止,对保护性免疫的研究仅在动物模型中进行,并且在人类中尚未建立保护相关性。在这里,我们描述了一艘渔船爆发的 SARS-CoV-2 疫情,该疫情具有较高的发病率。122 名船员中有 120 人在中位随访 32.5 天(范围 18.8 至 50.5 天)时进行了出发前的血清学和病毒逆转录-PCR(RT-PCR)检测,并在返回岸边后进行了重复检测。共有 104 人在随访期间进行了 RT-PCR 阳性病毒检测,其循环阈值( )<35 或发生血清转换,船上的发病率为 85.2%(104/122 人)。39 个病毒基因组的宏基因组测序表明,该疫情主要起源于一个单一的病毒分支。在最初的血清学筛查中,只有 3 名船员在登船前检测呈血清阳性,并且在后续检测中也具有中和和刺突反应性抗体。在病毒爆发期间,具有中和抗体滴度的船员均未显示出真正的病毒感染证据或出现任何症状。因此,先前感染产生的中和抗体与免受再感染显著相关(Fisher 精确检验,  = 0.002)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd6/7587101/57423def7238/JCM.02107-20-f0001.jpg

相似文献

3
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Immunity. 2020 Nov 17;53(5):925-933.e4. doi: 10.1016/j.immuni.2020.10.004. Epub 2020 Oct 14.
6
A serological survey of SARS-CoV-2 in cat in Wuhan.
Emerg Microbes Infect. 2020 Dec;9(1):2013-2019. doi: 10.1080/22221751.2020.1817796.
8
Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays.
J Immunol Methods. 2020 Nov;486:112837. doi: 10.1016/j.jim.2020.112837. Epub 2020 Aug 20.
10
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Science. 2020 Aug 7;369(6504):650-655. doi: 10.1126/science.abc6952. Epub 2020 Jun 22.

引用本文的文献

2
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine.
Clin Infect Dis. 2025 Jul 22;80(Supplement_1):S57-S65. doi: 10.1093/cid/ciaf095.
3
Mimicking immune complexes for efficient antibody responses.
Front Immunol. 2025 Apr 28;16:1570487. doi: 10.3389/fimmu.2025.1570487. eCollection 2025.
4
The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis.
Vaccines (Basel). 2025 Mar 30;13(4):368. doi: 10.3390/vaccines13040368.
7
Systemic inflammation is associated with worse outcomes from SARS-CoV-2 infection but not neutralizing antibody.
Microbiol Spectr. 2025 Apr;13(4):e0245924. doi: 10.1128/spectrum.02459-24. Epub 2025 Feb 19.
8
Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.
PLoS One. 2025 Feb 11;20(2):e0308850. doi: 10.1371/journal.pone.0308850. eCollection 2025.
9
Effect of Homologous and Heterologous Booster in COVID-19 Vaccination.
Pharmaceuticals (Basel). 2024 Dec 22;17(12):1734. doi: 10.3390/ph17121734.
10
SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study.
Infect Dis Rep. 2024 Nov 25;16(6):1084-1097. doi: 10.3390/idr16060088.

本文引用的文献

2
SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality.
Open Forum Infect Dis. 2020 Nov 3;7(12):ofaa535. doi: 10.1093/ofid/ofaa535. eCollection 2020 Dec.
3
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
4
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans.
Nat Microbiol. 2020 Dec;5(12):1598-1607. doi: 10.1038/s41564-020-00813-8. Epub 2020 Oct 26.
8
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.
Science. 2020 Oct 2;370(6512):89-94. doi: 10.1126/science.abd3871. Epub 2020 Aug 4.
9
Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs.
Clin Microbiol Infect. 2020 Nov;26(11):1557.e1-1557.e7. doi: 10.1016/j.cmi.2020.07.038. Epub 2020 Jul 31.
10
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.
Nature. 2020 Oct;586(7830):578-582. doi: 10.1038/s41586-020-2608-y. Epub 2020 Jul 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验